Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Simeón-Aznar

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Autoimmunity|November 24, 2015
Sequence analysis of TMEM173 exon 5 in patients with systemic autoimmune diseasesE Balada, A Selva-O'Callaghan, L Felip, et al.
Clinical and Experimental Rheumatology|July 28, 2006
Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosisE Balada, C P Simeón-Aznar, S Serrano-Acedo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 28, 2014
Prevalence of HHV-8 in systemic autoimmune diseasesE Balada, M Ramentol, L Felip, et al.
Lupus|February 18, 2003
Lack of evidence of foetal microchimerism in female Spanish patients with systemic sclerosisA Selva-O'Callaghan, T Mijares-Boeckh-Behrens, E Balada Prades, et al.
Clinical and Experimental Rheumatology|April 30, 2014
Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differencesC P Simeón-Aznar, C Tolosa-Vilella, L Gabarró-Juliá, et al.
The Open Respiratory Medicine Journal|April 3, 2009
Intravenous cyclophosphamide pulse therapy in the treatment of systemic sclerosis-related interstitial lung disease: a long term studyC P Simeón-Aznar, V Fonollosa-Plá, C Tolosa-Vilella, et al.
Lupus|May 4, 2004
Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromesR Solans-Laqué, C Pérez-Bocanegra, A Salud-Salvia, et al.
Annals of the Rheumatic Diseases|February 15, 2008
Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosisE Balada, C P Simeón-Aznar, J Ordi-Ros, et al.
Autoimmunity Reviews|July 15, 2018
Subclinical cardiovascular disease and Systemic Sclerosis: A comparison between risk charts, quantification of coronary calcium and carotid ultrasonographyI Sanz Pérez, F Martínez Valle, A Guillén-Del-Castillo, et al.
Rheumatology International|January 12, 2018
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study groupD Sánchez-Cano, N Ortego-Centeno, J L Callejas, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Autoimmunity|November 24, 2015
Sequence analysis of TMEM173 exon 5 in patients with systemic autoimmune diseasesE Balada, A Selva-O'Callaghan, L Felip, et al.
Clinical and Experimental Rheumatology|July 28, 2006
Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosisE Balada, C P Simeón-Aznar, S Serrano-Acedo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 28, 2014
Prevalence of HHV-8 in systemic autoimmune diseasesE Balada, M Ramentol, L Felip, et al.
Lupus|February 18, 2003
Lack of evidence of foetal microchimerism in female Spanish patients with systemic sclerosisA Selva-O'Callaghan, T Mijares-Boeckh-Behrens, E Balada Prades, et al.
Clinical and Experimental Rheumatology|April 30, 2014
Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differencesC P Simeón-Aznar, C Tolosa-Vilella, L Gabarró-Juliá, et al.
The Open Respiratory Medicine Journal|April 3, 2009
Intravenous cyclophosphamide pulse therapy in the treatment of systemic sclerosis-related interstitial lung disease: a long term studyC P Simeón-Aznar, V Fonollosa-Plá, C Tolosa-Vilella, et al.
Lupus|May 4, 2004
Clinical significance of antinuclear antibodies in malignant diseases: association with rheumatic and connective tissue paraneoplastic syndromesR Solans-Laqué, C Pérez-Bocanegra, A Salud-Salvia, et al.
Annals of the Rheumatic Diseases|February 15, 2008
Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosisE Balada, C P Simeón-Aznar, J Ordi-Ros, et al.
Autoimmunity Reviews|July 15, 2018
Subclinical cardiovascular disease and Systemic Sclerosis: A comparison between risk charts, quantification of coronary calcium and carotid ultrasonographyI Sanz Pérez, F Martínez Valle, A Guillén-Del-Castillo, et al.
Rheumatology International|January 12, 2018
Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study groupD Sánchez-Cano, N Ortego-Centeno, J L Callejas, et al.
Pageof 2